4
Changes in Ownership
Citius Pharmaceuticals, Inc. Filed Acc 0001013762-23-003528
Options or other derivatives
- Chief Executive Officer acquired 550,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mazur Leonard L · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-10 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +550,000 | 550,000 | D |
Loading xslF345X05/ownership.xml…